Back to top
more

UnitedHealth Group (UNH)

(Real Time Quote from BATS)

$569.04 USD

569.04
2,008,227

+3.01 (0.53%)

Updated Oct 18, 2024 02:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now

by Zacks Equity Research

Investors are optimistic about Myriad Genetics (MYGN) owing to strong Q1 2022 results and growth in testing volumes.

Here's Why You Should Retain Amedisys (AMED) Stock for Now

by Zacks Equity Research

Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.

IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern

by Zacks Equity Research

Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.

Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable

by Zacks Equity Research

Abbott's (ABT) study data presented at EuroPCR 2022 reinforces the company's commitment to offering structural heart solutions, supported by clinical evidence that exceeds existing standards of care.

Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger

by Zacks Equity Research

Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.

Should Vanguard Value ETF (VTV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VTV

The Zacks Analyst Blog Highlights Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi

by Zacks Equity Research

Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi have been included in this Analyst Blog.

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed the most recent trading day at $492.08, moving +1.31% from the previous trading session.

Sheraz Mian headshot

Top Stock Reports for Alphabet, UnitedHealth & Costco

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH), and Costco Wholesale Corporation (COST).

Here's Why Investors Should Retain Haemonetics (HAE) For Now

by Zacks Equity Research

Investors are optimistic about Haemonetics's (HAE) better-than-expected results and robust segmental performance.

Alcon (ALC) Signs EYSUVIS-Buyout Deal With Kala Pharmaceuticals

by Zacks Equity Research

The acquisition of EYSUVIS complements Alcon's (ALC) Systane family of eye drops offering, strengthening its treatment options for dry eye disease.

Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

by Zacks Equity Research

Investors are optimistic about Exact Sciences (EXAS) on impressive Q1 results and a bullish 2022 outlook.

Align Technology (ALGN) to Offer Asana Smiles With New Pact

by Zacks Equity Research

Align Technology's (ALGN) new partnership will give doctors access to an alternative that helps reduce manual processes and creates a clear view of Invisalign treatment workflows.

Why UnitedHealth Group (UNH) is a Top Stock for the Long-Term

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Align Technology (ALGN) Debuts Invisalign Outcome Simulator Pro

by Zacks Equity Research

The next-generation of Align Technology's (ALGN) advanced patient communication tool will help patients see their potential new smile after Invisalign treatment.

LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients

by Zacks Equity Research

LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.

Globus Medical (GMED) Completes First Cases With Excelsius3D

by Zacks Equity Research

Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

by Zacks Equity Research

Investors are optimistic about QIAGEN (QGEN), owing to strong international growth and bullish guidance.

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

by Zacks Equity Research

Sector ETF report for FHLC

Humana (HUM) Expands JV, To Invest $1.2B, Eyes 100 New Clinics

by Zacks Equity Research

Through the first JV, Humana (HUM) and its partner are pumping $800 million into developing 67 facilities by early 2023.

Here's Why Investors Should Retain Hologic (HOLX) Stock for Now

by Zacks Equity Research

Investors are optimistic about Hologic's (HOLX) better-than-expected results and robust segmental growth.

QIAGEN (QGEN) Unveils New Enhancements to QIAstat-Dx Portfolio

by Zacks Equity Research

The launch of QIAstat-Dx Rise and other advancements to the QIAstat-Dx portfolio are expected to strengthen QIAGEN's (QGEN) syndromic testing solutions.

Illumina's (ILMN) GRAIL, Intermountain Healthcare Expand Tie-Up

by Zacks Equity Research

Illumina (ILMN) subsidiary GRAIL's MCED blood test will be offered along with existing single cancer screenings to advance cancer care delivery through early detection.

Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now

by Zacks Equity Research

Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.

Community Health (CYH) Boosts Obstetrics Care With Technology

by Zacks Equity Research

Community Health (CYH) employs PeriGen's technology to bring about enhanced obstetrics services and assure the safety of mothers as well as babies in the labor and delivery procedures.